Ginkgo Bioworks (DNA) completed the first milestone of a partnership with Merck (MRK) focused on improving biologic manufacturing. As part of ...

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 ...

The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

PRNewswire/ -- "According to the latest BCC research study, the demand for Global Oncology Pharmaceuticals Market increased ...

If you’re on the fence about investing in Eli Lilly And Co or Merck & Co Inc because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

The data shows that 18 of these top 25 companies are based in the USA. The biggest company with most startup acquisitions is Alphabet with 222 acquisitions. It is followed by Microsoft with 140 ...

Germany’s Merck KGaA said this morning that the FDA has placed a partial clinical hold on its multiple sclerosis drug candidate evobrutinib, vying to become a new oral therapy for the disease.